FIELD: medicine, biochemistry. SUBSTANCE: extract is prepared from sapropel by three-fold volume of 0.1 M ammonium solution and extract is kept at -15 C for 24 h. After defrosting at the room temperature supernatant is decanted and concentrated by evaporation under vacuum. The concentrated fraction is centrifuged and dialyzed. Nondyalizable fraction is treated with ammonium sulfate at 100% degree of saturation and the formed precipitate is discarded. The purified fraction is desalted with 96% ethyl alcohol followed by gel-filtration on column with Sephadex G-50. Eluates are combined and dried. EFFECT: enhanced purity of end product. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING THE AGENT SHOWING ANTICOAGULATING ACTIVITY | 1995 |
|
RU2101023C1 |
METHOD FOR PREPARING SAPROPEL-BASE BIOLOGICALLY ACTIVE SUBSTANCE | 2001 |
|
RU2214254C2 |
METHOD FOR OBTAINING BIOLOGICALLY ACTIVE SUBSTANCES OUT OF LAMINARIA FOR MEDICINAL PURPOSES | 2001 |
|
RU2194525C1 |
METHOD OF QUANTITATIVELY DETERMINING MESOPAM | 2000 |
|
RU2206079C2 |
METHOD OF MEDICINAL PURIFIED SODIUM ALGINATE PREPARING | 2001 |
|
RU2197249C1 |
METHOD OF OBTAINING AND PURIFYING HUMAN INHIBIN-A | 2009 |
|
RU2434018C2 |
ANTICOAGULANT AGENT BASED ON HUMIC ACIDS OF LOW-MINERALIZED SILT SULFIDE MUD | 2022 |
|
RU2807928C1 |
METHOD OF PREPARING HEMICELLULOSES | 1999 |
|
RU2170236C2 |
METHOD FOR QUANTITATIVE DETERMINATION OF DIMEDROL | 2002 |
|
RU2240537C2 |
METHOD FOR PRODUCTION OF CONCENTRATED SAPROPEL | 1992 |
|
RU2005478C1 |
Authors
Dates
2001-11-10—Published
2000-03-16—Filed